Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

scientific article published in September 2006

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JPSYCHIRES.2006.07.002
P698PubMed publication ID16949099
P5875ResearchGate publication ID6841010

P50authorThomas SuslowQ71744117
Bettina PfleidererQ88663737
Patricia OhrmannQ96111838
Anya PedersenQ96111842
Anette KerstingQ96247354
Volker AroltQ110551284
Walter HeindelQ114270429
Ansgar SiegmundQ116997285
Matthias RothermundtQ116997286
Katharina SpitzbergQ116997288
P433issue8
P921main subjectschizophreniaQ41112
patientQ181600
cognitive dysfunctionQ57859955
P304page(s)625-634
P577publication date2006-09-01
P1433published inJournal of Psychiatric ResearchQ6295810
P1476titleCognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study
P478volume41